IL2RG and neoplasm: Subcutaneous tumor growth has been demonstrated in a proof-of-principle study with implantation of human PC cells (Panc01) into the ears of immunodeficient transgenic pigs (RAG2/IL2RG deficient) (Hendricks-Wenger et al., 2021).